14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
GMOC vs GMOV: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, GMOC (GMOC) is the stronger overall head-to-head candidate over GMO US Value ETF (GMOV) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). GMOC carries a Unified Composite Score of 55.2/100 (HOLD) at $50.20 (N/M Forward P/E, N/A operating margin), whereas GMOV carries 40.8/100 (SELL) at $31.16 (N/M Forward P/E, N/A operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GMOC vs GMOV. Trailing 12-month operating profitability (GMOC N/A vs GMOV N/A) and valuation multiples (GMOC N/M vs GMOV N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ GMOC vs GMOV Key Questions & Quantitative Answers
As of Nov 20, 2026, GMOC (GMOC) is the stronger overall head-to-head candidate over GMO US Value ETF (GMOV) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). GMOC carries a Unified Composite Score of 55.2/100 (HOLD) at $50.20 (N/M Forward P/E, N/A operating margin), whereas GMOV carries 40.8/100 (SELL) at $31.16 (N/M Forward P/E, N/A operating margin). Technically, GMOC sits in a Neutral phase (RSI 60.3, UNCLASSIFIED options structure) and GMOV sits in a Neutral phase (RSI 30.6, UNCLASSIFIED options structure).
GMOC and GMOV split Growth & Scale metrics: GMOC posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with GMOV at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, GMOC generates N/A in USD-normalized revenue versus N/A for GMOV. In operating R&D and SG&A reinvestment, GMOC deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for GMOV.
GMOC and GMOV trade at balanced relative valuation multiples. GMOC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas GMOV trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GMOC (N/A ROE) versus GMOV (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, GMOC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.00β · 1% Vol realized risk). By comparison, GMOV carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.38β · 17% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.